abstract |
(57) Abstract The present invention relates to human fibroblast growth factor (hFGF-23), cleavage products of hFGF-23, and variants thereof, and polynucleotides encoding FGF-23. The invention also relates to diagnostic and therapeutic factors (including probes and antibodies) associated with polynucleotides and proteins, and methods of treating skin, brain, and placenta diseases and disorders, and treating conditions associated with thymic function On how to do. The present invention also relates to mouse fibroblast growth factor (mFGF-23), and variants thereof, and polynucleotides encoding mFGF-23. |